Researchers have uncovered a surprising connection between a cancer-related signaling pathway and the blood-brain and blood-retina barriers. The study shows that the tumor-suppressing protein p53 weakens the Norrin/Frizzled4 pathway, which is crucial for maintaining these protective barriers.